AR022072A1 - Terapias y composiciones para tratar enfermedades pulmonares - Google Patents

Terapias y composiciones para tratar enfermedades pulmonares

Info

Publication number
AR022072A1
AR022072A1 ARP990104234A ARP990104234A AR022072A1 AR 022072 A1 AR022072 A1 AR 022072A1 AR P990104234 A ARP990104234 A AR P990104234A AR P990104234 A ARP990104234 A AR P990104234A AR 022072 A1 AR022072 A1 AR 022072A1
Authority
AR
Argentina
Prior art keywords
therapies
compositions
pulmonary diseases
treat pulmonary
beta
Prior art date
Application number
ARP990104234A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AR022072A1 publication Critical patent/AR022072A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Terapias para tratar enfermedades pulmonares tales como la enfermedad pulmonar obstructiva cronica o el asma, por administracion de un inhibidor defosfodiesterasa 4 en combinacion con un broncodilatador beta-adrenérgico. Composiciones que incluye dicho inhibidor de fosfodiesterasa en combinacion con unbroncodilatador beta-adrenérgico.
ARP990104234A 1998-08-26 1999-09-03 Terapias y composiciones para tratar enfermedades pulmonares AR022072A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9797398P 1998-08-26 1998-08-26

Publications (1)

Publication Number Publication Date
AR022072A1 true AR022072A1 (es) 2002-09-04

Family

ID=22266001

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990104234A AR022072A1 (es) 1998-08-26 1999-09-03 Terapias y composiciones para tratar enfermedades pulmonares

Country Status (21)

Country Link
US (2) US6288118B1 (es)
EP (1) EP1107747A4 (es)
JP (1) JP2002523452A (es)
KR (1) KR20010072931A (es)
CN (1) CN1314811A (es)
AR (1) AR022072A1 (es)
AU (1) AU754379B2 (es)
BR (1) BR9913152A (es)
CA (1) CA2341488A1 (es)
CZ (1) CZ293735B6 (es)
DZ (1) DZ2876A1 (es)
HU (1) HUP0103160A3 (es)
IL (1) IL141335A0 (es)
MA (1) MA26302A1 (es)
MY (1) MY126544A (es)
NO (1) NO20010882L (es)
NZ (1) NZ527232A (es)
PE (1) PE20001032A1 (es)
PL (1) PL346271A1 (es)
TR (1) TR200100500T2 (es)
WO (1) WO2000012078A1 (es)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525018B1 (en) * 1999-05-17 2003-02-25 The General Hospital Corp. Treating eye disorders using intestinal trefoil proteins
US6624181B1 (en) 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
US20030186882A1 (en) * 2001-07-31 2003-10-02 Podolsky Daniel K. Methods and compositions for treating and preventing distal bowel lesions
US20030185838A1 (en) * 2001-11-28 2003-10-02 Podolsky Daniel K. Methods and compositions for treating lesions of the respiratory epithelium
MY126544A (en) * 1998-08-26 2006-10-31 Smithkline Beecham Corp Therapies for treating pulmonary diseases
US8933032B2 (en) 1998-10-20 2015-01-13 Children's Hospital Medical Center Surfactant protein D for the treatment of disorders associated with lung injury
MXPA02001830A (es) * 1999-08-21 2002-08-12 Byk Gulden Lomberg Chem Fab Combinacion sinergica de inhibidores de pde y agonista de beta 2 adrenoceptor.
AU6233201A (en) 2000-06-05 2001-12-17 Byk Gulden Lomberg Chem Fab Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors
US20030105016A1 (en) * 2001-09-06 2003-06-05 Podolsky Daniel K. Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
US20060189526A1 (en) * 2002-04-24 2006-08-24 Podolsky Daniel K Compositions containing an intestinal trefoil peptide and a mucoadhesive
US7538082B2 (en) 2001-04-24 2009-05-26 The General Hospital Corporation Methods and compositions for treating oral and esophageal lesions
US20040171544A1 (en) * 2001-04-24 2004-09-02 Barker Nicholas P. Trefoil domain-containing polypeptides and uses thereof
US20030181384A1 (en) * 2001-09-06 2003-09-25 Podolsky Daniel K. Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
CN1599619A (zh) * 2001-10-05 2005-03-23 综合医院公司 治疗真皮损伤的方法和组合物
US20030185839A1 (en) * 2001-10-05 2003-10-02 Podolsky Daniel K. Methods and compositions for treating dermal lesions
US7931022B2 (en) * 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
WO2003045332A2 (en) * 2001-11-28 2003-06-05 The General Hospital Corporation Methods and compositions for treating lesions of the respiratory epithelium
GB0129395D0 (en) * 2001-12-07 2002-01-30 Pfizer Ltd Pharmaceutical combination
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
AU2003224773B2 (en) * 2002-03-26 2010-08-26 The General Hospital Corporation Combination therapy using trefoil peptides
AU2003227710A1 (en) * 2002-05-07 2003-11-11 Altana Pharma Ag New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders
DE10220459A1 (de) * 2002-05-07 2003-11-27 Byk Gulden Lomberg Chem Fab Neue Kombination zur Behandlung von Atemwegserkrankungen
US20050165041A1 (en) * 2002-05-07 2005-07-28 Altana Pharma Ag Combination for the treatment of airway disorders
DE10220458A1 (de) * 2002-05-07 2003-11-27 Altana Pharma Ag Kombination zur Behandlung von Atemwegserkrankungen
US20060188471A1 (en) * 2002-10-31 2006-08-24 Podolsky Daniel K Methods of treating epithelial lesions
EP1567140B1 (en) * 2002-11-27 2008-07-02 Nycomed GmbH Synergistic combination comprising roflumilast and (r,r)-formoterol
DK1567139T3 (da) * 2002-11-27 2008-11-03 Nycomed Gmbh Hidtil ukendt synergistisk kombination der omfatter roflumilast og formoterol
KR101179012B1 (ko) 2003-03-10 2012-09-03 니코메드 게엠베하 로플루미라스트 신규한 제조 방법
JPWO2004087151A1 (ja) * 2003-03-31 2006-06-29 協和醗酵工業株式会社 医薬組成物
SE527200C2 (sv) * 2003-06-19 2006-01-17 Microdrug Ag Inhalatoranordning samt kombinerade doser av formaterol och fluticason
CA2570386A1 (en) * 2004-06-14 2005-12-29 Sepracor Inc. Methods of using albuterol and calcium activated potassium channel openers
JP2008502699A (ja) * 2004-06-14 2008-01-31 セプラコール・インコーポレイテッド 肺疾患治療方法、及びそのための組成物
EP1861074B1 (en) 2005-03-16 2013-04-24 Takeda GmbH Taste masked dosage form containing roflumilast
DE102005030733A1 (de) * 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
US20090182035A1 (en) * 2007-04-11 2009-07-16 Alcon Research, Ltd. Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
WO2008127975A2 (en) * 2007-04-11 2008-10-23 Alcon Research, Ltd. Use of an inhibitor of tnfa plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
ES2618881T3 (es) * 2009-04-22 2017-06-22 Indiana University Research And Technology Corporation Colágeno V para su uso en el tratamiento del asma
EP2482798A1 (en) * 2009-10-01 2012-08-08 Alcon Research, Ltd. Olopatadine compositions and uses thereof
KR101035488B1 (ko) * 2009-10-05 2011-05-20 숭실대학교산학협력단 자동차 블랙박스 영상물 수집 방법
WO2011056561A1 (en) 2009-10-27 2011-05-12 Beth Israel Deaconess Medical Center Methods and compositions for the generation and use of conformation-specific antibodies
AU2011253203A1 (en) 2010-05-10 2012-11-22 Gilead Sciences, Inc. Bifunctional quinoline derivatives
WO2011143106A1 (en) 2010-05-10 2011-11-17 Gilead Sciences, Inc. Bi - functional pyrazolopyridine compounds
US10487114B2 (en) 2011-04-27 2019-11-26 Beth Israel Deaconess Medical Center, Inc. Methods for administering peptides for the generation of effective c/s conformation-specific antibodies to a human subject in need thereof
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof
US10433624B2 (en) * 2015-03-26 2019-10-08 Nike, Inc. Duffel bag
WO2019157144A1 (en) 2018-02-07 2019-08-15 Duke University System and method for homogenous gpcr phosphorylation and identification of beta-2 adrenergic receptor positive allosteric modulators

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791025A (fr) 1971-11-19 1973-05-07 Allen & Hanburys Ltd Composes heterocycliques
GB1457873A (en) 1973-01-04 1976-12-08 Allen & Hanburys Ltd Imidazotriazines
FR2390164A1 (fr) 1977-05-13 1978-12-08 Blanie Paul Association a action anti-asthmatique
US5602110A (en) 1994-08-31 1997-02-11 Case Western Reserve University Method and composition for treating cystic fibrosis
FR2753706B1 (fr) * 1996-09-20 1998-10-30 Nouvelles amines cycliques n-substituees, leur procede de preparation et les compositions pharmaceutiques les renfermant
FR2753969B1 (fr) * 1996-09-27 1998-10-30 Adir Nouveaux derives de flavones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO1998037894A1 (de) * 1997-02-28 1998-09-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistische kombination von pde-hemmern und adenylatcyclase-agonisten bzw. guanylcyclyse-agonisten
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
MY126544A (en) * 1998-08-26 2006-10-31 Smithkline Beecham Corp Therapies for treating pulmonary diseases

Also Published As

Publication number Publication date
AU754379B2 (en) 2002-11-14
NO20010882D0 (no) 2001-02-21
DZ2876A1 (fr) 2003-12-15
US20010056122A1 (en) 2001-12-27
CZ293735B6 (cs) 2004-07-14
BR9913152A (pt) 2001-05-15
NZ527232A (en) 2005-03-24
PE20001032A1 (es) 2000-11-10
AU5493999A (en) 2000-03-21
MA26302A1 (fr) 2004-10-01
MY126544A (en) 2006-10-31
US6555583B2 (en) 2003-04-29
HUP0103160A3 (en) 2002-11-28
JP2002523452A (ja) 2002-07-30
PL346271A1 (en) 2002-01-28
CZ2001692A3 (cs) 2002-02-13
EP1107747A4 (en) 2003-04-23
KR20010072931A (ko) 2001-07-31
CN1314811A (zh) 2001-09-26
EP1107747A1 (en) 2001-06-20
HUP0103160A2 (hu) 2002-01-28
CA2341488A1 (en) 2000-03-09
NO20010882L (no) 2001-02-21
US6288118B1 (en) 2001-09-11
TR200100500T2 (tr) 2001-06-21
IL141335A0 (en) 2002-03-10
WO2000012078A1 (en) 2000-03-09

Similar Documents

Publication Publication Date Title
AR022072A1 (es) Terapias y composiciones para tratar enfermedades pulmonares
UY28958A1 (es) Nuevos derivados de piridazin-3(2h)-ona
BR0007492A (pt) Jogo de piso para formação de equipe
BR0107934A (pt) Carboxamidas de pirimidina úteis como inibidores de isozimas pde4
MXPA02011311A (es) Composicion novedosa.
BRPI0414425A (pt) composições farmacêuticas
BR0008699A (pt) Combinações de formoterol e furoato demometasona para asma
UY26959A1 (es) Nuevos polvos para inhalación que contienen tiotropio
BR9913855A (pt) 1-2-3-4- tetrahidroquinolinas substituìdas na posição 2 e substituìdas na posição 4 com amino como inibidores de cetp
BR0115847A (pt) Compostos especìficos para receptor para adenosina a1, a2a, e a3 e usos dos mesmos
CO5160320A1 (es) Metodos y composiciones para la prevencion de tolerancia a medicamentos das.
ECSP067043A (es) Derivados de pirrolotriazina útiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogénesis
WO2002083079A3 (en) Aerosol compositions containing formoterol for delivery to the lungs via nebulization
WO2005020885A3 (en) Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
BR9913319A (pt) Composições e métodos para tratamento de doenças mitocondriais
AR042578A1 (es) Inhibidores de la sintesis de mucina
BRPI0407454A (pt) Pirazóis e métodos de preparar e usar os mesmos
ES2093130T3 (es) Forma de ciclosporin para administracion pulmonar.
BR0107964A (pt) Derivados de nicotinamida benzofundida com heterociclica úteis como inibidores seletivos de isozimas pde4
BR0211450A (pt) Método terapêutico
BR0209992A (pt) Inibidor de pde4 e um agente anticolinérgico em combinação para o tratamento de doenças obstrutivas das vias respiratórias
WO2003034995A3 (en) Integrin targeting compounds
PA8542901A1 (es) Uso de (z)-2-ciano-3-hidroxi-but-2-acido enoico-(4-trifluorometilfenil)-amida para tratar la esclerosis multiple
SE9900833D0 (sv) Novel combination
BRPI0409742A (pt) uso de um agente anti-angiogênico, em combinação com um inibidor da famìlia src de tirosina quinases não-receptoras, produto de combinação, e, composição farmacêutica

Legal Events

Date Code Title Description
FA Abandonment or withdrawal